{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:41:21Z","timestamp":1784688081102,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Serological pattern of simultaneous positivity for hepatitis B surface antigen (HBsAg) and antibody against HBsAg (anti-HBs) is considered a specific and atypical phenomenon among patients with chronic hepatitis B virus (HBV) infection, especially in pediatric patients. Unfortunately, there is limited understanding of the clinical and virological characteristics among children having chronic HBV infection and the coexistence of HBsAg and anti-HBs. Hence, our objective was to determine the prevalence of coexistent HBsAg and anti-HBs and to explore the associated clinical and virological features in this patient population. The researchers conducted a retrospective cohort study on the 413 pediatric patients with chronic HBV infection from December 2011 to June 2022. The patients were stratified into two groups based on their anti-HBs status. Demographic, serum biochemical and virological parameters of two group were compared. Of the total 413 enrolled subjects, 94 (22.8%) were tested positive for both HBsAg and anti-HBs. Patients with anti-HBs were younger and demonstrated significantly higher ratio of albumin to globulin (A\/G), elevated serum levels of alanine transaminase (ALT), lower ratio of aspartate transaminase (AST)\/ALT (AST\/ALT) and reduced serum levels of globulin, HBsAg and HBV DNA, Additionally, these patients were more likely to show coexistent HBeAg and anti-HBe when compared to patients without anti-HBs. The results of multivariate logistical analysis revealed that AST\/ALT, serum levels of globulin and HBsAg were negatively associated with coexistence of HBsAg and anti-HBs. Our data demonstrated a considerable prevalence of coexisting HBsAg and anti-HBs in pediatric patients. Children with this specific serological pattern were commonly of a younger age, seemly predisposing them to early liver impairment and lower HBV replication activity.<\/jats:p>","DOI":"10.3389\/fpubh.2024.1380771","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T04:51:57Z","timestamp":1718599917000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and virological characteristics of coexistent hepatitis B surface antigen and antibody in treatment-naive children with chronic hepatitis B virus infection"],"prefix":"10.3389","volume":"12","author":[{"given":"Yi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShuangJie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenXian","family":"OuYang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingping","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songxu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S2468-1253(19)30042-1","article-title":"Hepatitis B virus infection in children and adolescents","volume":"4","author":"Indolfi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/jvh.12492","article-title":"Epidemiological characteristics of the carriers with coexistence of HBsAg and anti-HBs based on a community cohort study","volume":"23","author":"Pu","year":"2016","journal-title":"J Viral Hepat"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.7150\/ijbs.55724","article-title":"Paradoxical HBsAg and anti-HBs coexistence among chronic HBV infections: causes and consequences","volume":"17","author":"Jiang","year":"2021","journal-title":"Int J Biol Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.12659\/msm.905033","article-title":"Patients with coexistence of circulating hepatitis B surface antigen and its antibody may have a strong predisposition to virus reactivation during immunosuppressive therapy: a hypothesis","volume":"23","author":"Chen","year":"2017","journal-title":"Med Sci Monit"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e2216485","DOI":"10.1001\/jamanetworkopen.2022.16485","article-title":"Association of Coexistent Hepatitis B Surface Antigen and Antibody with Severe Liver Fibrosis and cirrhosis in treatment-naive patients with chronic hepatitis B","volume":"5","author":"Wang","year":"2022","journal-title":"JAMA Netw Open"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bjid.2019.08.007","article-title":"Coexistence of low levels of HBsAg and high levels of anti-HBs may increase risk of hepatocellular carcinoma in chronic hepatitis B patients with high HBV load","volume":"23","author":"Jin","year":"2019","journal-title":"Braz J Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/jmv.23779","article-title":"Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study","volume":"86","author":"Seo","year":"2014","journal-title":"J Med Virol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jvh.13312","article-title":"Prevalence and clinical features of patients with concurrent HBsAg and anti-HBs: evaluation of the hepatitis B research network cohort","volume":"27","author":"Lee","year":"2020","journal-title":"J Viral Hepat"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1086\/513200","article-title":"Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection","volume":"44","author":"Zhang","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e0146980","DOI":"10.1371\/journal.pone.0146980","article-title":"Clinical and Virological characteristics of chronic hepatitis B patients with coexistence of HBsAg and anti-HBs","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/j.1478-3231.2005.01157.x","article-title":"Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan)","volume":"25","author":"Yen","year":"2005","journal-title":"Liver Int"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1478-3231.2008.01941.x","article-title":"Natural history of chronic hepatitis B virus infection and long-term outcome under treatment","volume":"29","author":"Liaw","year":"2009","journal-title":"Liver Int"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2020.200412","article-title":"Virology and serological characteristics of chronic hepatitis B patients with the co-existence of HBsAg and anti-HBs antibodies","volume":"66","author":"Zhu","year":"2020","journal-title":"Clin Lab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4238\/gmr16019102","article-title":"A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies","volume":"16","author":"Xiang","year":"2017","journal-title":"Genet Mol Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1086\/513296","article-title":"The enigma of concurrent hepatitis B surface antigen (HBsAg) and antibodies to HBsAg","volume":"44","author":"Gerlich","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jcv.2011.07.011","article-title":"Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs","volume":"52","author":"Chen","year":"2011","journal-title":"J Clin Virol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/jvh.12899","article-title":"Identified OAS3 gene variants associated with coexistence of HBsAg and anti-HBs in chronic HBV infection","volume":"25","author":"Wang","year":"2018","journal-title":"J Viral Hepat"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jmv.21669","article-title":"Pre S deletion mutations of hepatitis B virus in chronically infected patients with simultaneous seropositivity for hepatitis-B surface antigen and anti-HBS antibodies","volume":"82","author":"Huang","year":"2010","journal-title":"J Med Virol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bjid.2015.08.014","article-title":"Mutations in the S gene and in the overlapping reverse transcriptase region in chronic hepatitis B Chinese patients with coexistence of HBsAg and anti-HBs","volume":"20","author":"Ding","year":"2016","journal-title":"Braz J Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4161\/hv.34306","article-title":"Hepatitis B vaccination","volume":"11","author":"Roman\u00f2","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.virol.2007.05.012","article-title":"Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers","volume":"367","author":"Colson","year":"2007","journal-title":"Virology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.3390\/ijms22115497","article-title":"Immunopathology of chronic hepatitis B infection: role of innate and adaptive immune response in disease progression","volume":"22","author":"Khanam","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/jmv.25080","article-title":"Relationship between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients","volume":"90","author":"Yang","year":"2018","journal-title":"J Med Virol"},{"key":"ref28","first-page":"2061","article-title":"Relationship between HBV DNA load and levels of serum HBsAg in patients with chronic hepatitis B","volume":"20","author":"Zhu","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"10395","DOI":"10.3748\/wjg.v20.i30.10395","article-title":"Natural history of chronic hepatitis B: phases in a complex relationship","volume":"20","author":"Croagh","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/occmed\/kqr136","article-title":"Hepatitis B prevention, diagnosis, treatment and care: a review","volume":"61","author":"Aspinall","year":"2011","journal-title":"Occup Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1016\/s1386-6532(05)80024-1","article-title":"The natural history of chronic hepatitis B virus infection","volume":"34","author":"Villeneuve","year":"2005","journal-title":"J Clin Virol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.19914\/j.cjvi.2015.04.004","article-title":"Prevalence of hepatitis B virus surface antigen (HBsAg) and antibody to HBsAg among 1-59 year olds, Hunan Province","volume":"21","author":"Xia","year":"2015","journal-title":"Chinese J Vaccin Iimmunization"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1136\/gutjnl-2023-330691","article-title":"Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people","volume":"72","author":"Liu","year":"2023","journal-title":"Gut"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1380771\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T04:52:01Z","timestamp":1718599921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1380771\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":33,"alternative-id":["10.3389\/fpubh.2024.1380771"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2024.1380771","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,17]]},"article-number":"1380771"}}